x

Posted 03 February, 2022

QUEST DIAGNOSTICS INC appointed James E. Davis as new CEO

NYSE:DGX appointed new Chief Executive Officer James E. Davis in a 8-K filed on 03 February, 2022.


  On February 3, 2022, the Company announced that its Board of Directors (the "Board"), as part of its ongoing leadership succession planning, has appointed James E. Davis, currently Executive Vice President, General Diagnostics, to be its next Chief Executive Officer and President, effective November 1, 2022.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of QUEST DIAGNOSTICS INC
Health Care/Life Sciences • Healthcare Provision
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Market Cap
$19.1B
View Company Details
QUEST DIAGNOSTICS INC by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers


On February 3, 2022, the Company announced that its Board of Directors (the "Board"), as part of its ongoing leadership succession planning, has appointed James E. Davis, currently Executive Vice President, General Diagnostics, to be its next Chief Executive Officer and President, effective November 1, 2022. In addition, Mr. Davis was appointed Chief Executive Officer - Elect, effective February 3, 2022.


On November 1, 2022, Mr. Davis will succeed Stephen H. Rusckowski, who will have served as Chief Executive Officer and President for more than a decade. Mr. Rusckowski, 64, currently Chairman, Chief Executive Officer and President, will continue to serve on the Board as Executive Chairman through March 2023.


Mark J. Guinan, the Company's Executive Vice President and Chief Financial Officer, will retire in 2022. The Company has begun a search to identify Mr. Guinan's successor. Mr. Guinan will participate in the selection process and is expected to remain in his role through the transition.


Mr. Davis is not party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no family relationships between Mr. Davis and any director or executive officer of the Company. There are no arrangements or understandings between Mr. Davis and any person, including any officer or director of the Company, pursuant to which Mr. Davis was selected to serve as Chief Executive Officer.


A copy of the press release announcing these management changes is attached hereto as Exhibit 99.1 and is incorporated herein by reference.